Revolutionizing Neuroscience: Healing the Brain and Spine

Transcription

1 Revolutionizing Neuroscience: Healing the Brain and Spine Brain Tumors, Alzheimer s, Spine Surgery, Pediatric Neurosurgery & more Please join the MIT Enterprise Forum and Memorial Hermann Mischer Neuroscience Institute to explore how research and technology are driving advances in the field of neuroscience. Dr. Kiwon Lee, Director of Neurocritical Care, will lead a team of experts from the Mischer Neuroscience Institute to discuss the latest developments in diagnosis and treatment of brain tumors and Alzheimer s disease, and innovations in spine surgery and pediatric neurosurgery. When Wednesday, May 15, :00 PM - 8:30 PM 6:00 PM Reception with hors d'oeuvres, 6:30 PM Program Where Memorial Hermann-Texas Medical Center Hermann Conference Center 6411 Fannin Houston, Texas (free valet parking) Register at $15 Memorial Hermann Staff, Employees, and Students $30 MITEF Members General Admission $45 $55 Late Registration -- after 5PM, Monday May 13th, pending availability

2 For more information contact Dale Wilkins (713) , Complimentary Parking is located at the Fannin Street Valet off of Cambridge St. Directions to the Hermann Conference Center: 1. From the Fannin Street Valet, proceed to the Cullen Atrium 2. Descend escalators to the ground floor; Hermann Conference Center is at bottom of escalator

3 Presentations Brain Tumors: Advances in Neuro-Oncology Dong Kim, M.D. Director, Mischer Neuroscience Institute Chief of Neurosurgery Memorial Hermann-Texas Medical Center Professor and Chair, Vivian L. Smith Department of Neurosurgery Alzheimer's: Revolutionizing Diagnosis and Treatment Paul Schulz, M.D. Professor and Vice Chair, Department of Neurology Director, Dementia Program New Treatments for Back Pain Geoffrey Zubay, M.D. Clinical Assistant Professor, Vivian L. Smith Department of Neurosurgery New Approaches To Pediatric Neurosurgery David I. Sandberg, M.D. Director, Pediatric Neurosurgery Mischer Neuroscience Institute Associate Professor, Vivian L. Smith Department of Pediatric Surgery Moderator Kiwon Lee, M.D. Director, Neurocritical Care Mischer Neuroscience Institute Memorial Hermann-TMC Associate Professor and Vice Chair of Critical Care, Department of Neurology and Vivian L. Smith Department of Neurosurgery

4 About the Speakers Dong H. Kim, M.D. As director of the Mischer Neuroscience Institute (MNI) since October 2007, Dr. Dong H. Kim leads the clinical neuroscience efforts for the Memorial Hermann Health System as well as The University of Texas Health Science Center at Houston (UTHealth) Medical School. Combining the strengths of an 12-campus hospital group with 3,600 patient care beds and the academic resources of the UT System, MNI provides the most specialized treatment available for diseases of the brain and spine and is a national leader in research for new treatments. Dr. Kim is noted for his research into the origin, development and treatment of brain aneurysms. He leads basic science efforts, such as identifying the genes that lead to an inherited risk for aneurysms and genetic changes in brain tumors, and translational projects that directly affect clinical practice. He has been honored with numerous awards and was named to America s Top Surgeons, Marquis Who s Who and Who s Who in America. He is the recipient of grants from the National Institutes of Health and the American Stroke Association and has authored studies published in journals such as Nature Genetics, Brain Research, International Journal of Cancer, Neurology, Neurosurgery, Journal of Neurosurgery and Genes, Chrom, and Cancer. Dr. Kim is a graduate of Stanford University and the University of California, San Francisco (UCSF) School of Medicine. After general surgery training at Harvard, he completed his neurosurgery training under Dr. Charles Wilson at UCSF. He went on to complete a fellowship in cerebrovascular surgery and skull base tumors with Dr. Arthur Day. He has held faculty and hospital appointments at Harvard Medical School, Brigham and Women s Hospital, the Dana-Farber Cancer Institute, Cornell University Medical College, The New York Hospital and Memorial Sloan Kettering Cancer Center. Kiwon Lee, M.D., FACP, FAHA, FCCM Dr. Kiwon Lee is an academic neuro-intensivist. A graduate of Columbia University, he received formal training in cerebrovascular disease, neurological and neurosurgical critical care from Harvard Medical School Massachusetts General Hospital and Brigham and Women s Hospital in Boston, Massachusetts. He joined Jefferson Medical College of Thomas Jefferson University, Philadelphia in 2005 and served as the Director of the Neuro-Intensive Care Unit and Program Director of the Neuro-Critical Care Fellowship. He served as a faculty staff at the Jefferson Stroke Center, where he had an active role in acute management of all stroke victims. In 2007, he was recruited to Columbia University College of Physicians and Surgeons in New York. As a full time faculty attending for the Neurological Intensive Care Unit at Columbia Presbyterian Medical Center, he specialized in the treatment of critically ill, acute brain injury patients using the latest breakthroughs in ICU technologies. He has trained multiple generations of both neurology and neurosurgery trainees as well as a large group of critical care fellows including those in neurocritical care, anesthesia surgical critical care and pulmonary critical care. He has served on hospital quality assurance committees and multidisciplinary, interdepartmental stroke and critical care committees at the New York Presbyterian Columbia University Medical Center. Since 2012, Dr. Lee has taken a leadership position as the Director of Neurocritical Care at the Memorial Hermann-Texas Medical Center. He is an associate professor of Neurology and Neurosurgery, as well as Vice Chairman of Critical Care for the Departments of Neurosurgery and Neurology at the. He is the editor-in-chief of a formal textbook in neurocritical care, The Neuro-ICU Book, and has more than 120 peer-reviewed publications. Dr. Lee is involved in many ongoing national and international research projects. His research focuses on acute interventional stroke therapies and advanced treatment of delayed ischemic neurological deficits after subarachnoid hemorrhages. He has been actively involved in hemostasis research as well as advanced cardiac output monitoring research for severe brain injury patients. He has been invited to give numerous keynote speeches and grand rounds, as well as CME and special lectures around the world. Dr. David Sandberg Dr. Sandberg comes from Miami Children's Hospital and the University of Miami Miller School of Medicine, where he was a voluntary associate professor of clinical neurological surgery and pediatrics. At the, he holds joint appointments as an associate professor in the departments of Neurosurgery and Pediatric Surgery. His major clinical interests

5 include pediatric brain tumors, minimally invasive endoscopic approaches to brain tumors and hydrocephalus, congenital spinal anomalies, vascular malformations, spasticity, and craniofacial disorders in children. Dr. Sandberg is a fellow of the American College of Surgeons and the American Academy of Pediatrics and a member of the American Society for Pediatric Neurosurgery. He is a diplomate of the American Board of Neurological Surgery and the American Board of Pediatric Neurological Surgery. He received his undergraduate degree from Harvard University, his medical degree from the Johns Hopkins University School of Medicine, and completed neurosurgery residency training at Weill Medical College of Cornell University/New York Presbyterian Hospital. Dr. Sandberg was awarded the Resident Traveling Fellowship in Pediatric Neurosurgery by the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), and he completed this fellowship at the Hospital for Sick Children in Toronto, Canada. After residency, he completed fellowship training in pediatric neurosurgery at the Children's Hospital Los Angeles, which is affiliated with the Keck School of Medicine of the University of Southern California. Dr. Sandberg is editor of the ISPN Guide to Pediatric Neurosurgery, Tumor Section, and is an ad hoc reviewer for a number of neurosurgery and neuroscience journals. He has co-authored textbook chapters and numerous manuscripts in peer-reviewed journals including Neurosurgery, Journal of Neurosurgery: Pediatrics, Journal of Neuro-Oncology, Journal of Child Neurology and Pediatric Neurosurgery. Dr. Paul Schulz Paul Schulz, M.D., is an associate professor and Vice Chair of Neurology, and Director of the Neurocognitive Disorders Center at The University of Texas Health Science Center at Houston (UTHealth) Medical School. He received his combined BA-MD degrees from Boston University in He did a medical internship there, and moved to Baylor College of Medicine for his Residency in Neurology. He stayed for a laboratory Fellowship in Cellular Neurophysiology after which he became an Assistant Professor. Later, he was an Associate Professor of Neurology, Neuroscience, and Translational Biology and Molecular Medicine. He was also the Vice Chair of Education for Neurology, the Deputy Chair of the Methodist Neurology Service, and Directed the Cognitive Disorders Clinics at Baylor and the Houston Veterans Administration Hospital. In 2010, Dr. Schulz moved to Mischer Neuroscience Institute, where sees patients who have cognitive, behavioral, or mood disorders. His group is investigating risk factors for dementia in order to understand why it develops, including both environmental and genetic factors. They use imaging, epidemiologic, and genetic approaches and have identified several risks. They are also investigating ways to diagnose dementia earlier, perhaps before symptoms develop, in order to ascertain whether interventions in the presymptomatic stage might delay or prevent the development of dementia. His group has early data suggesting that the treatment of some risk factors may reduce the probability of developing dementia. Dr. Schulz has received numerous awards and has been an invited speaker at major scientific meetings worldwide. He has been extensively published in the scientific literature and has been featured on television and radio shows. Geoffrey P. Zubay, M.D., F.A.C.S. Dr. Geoffrey P. Zubay is a board-certified neurosurgeon with fellowship training in complex spinal reconstructive surgery. He also specializes in complex brain and cerebrovascular surgery. Dr. Zubay received his medical degree from Columbia University College of Physicians and Surgeons. He subsequently completed his neurosurgical residency at the Barrow Neurological Institute in Phoenix, Arizona, where he also continued his fellowship training in spinal surgery. Dr. Zubay completed a second fellowship with an emphasis on complex reconstructive spinal surgery at Northwestern University. These opportunities were afforded when he was honored with the Congress of Neurological Surgeons Clinical Fellowship Award in Prior to joining Mischer Neuroscience Institute, Mischer Neuroscience Associates and, Dr. Zubay had a successful neurosurgery practice in San Diego. His practice included seven years covering Level 1 neurosurgical trauma. Today, his practice reflects a continued emphasis on complex brain and cerebrovascular surgery and current spinal techniques, including both minimally invasive techniques and large corrective deformity techniques.

6